Product
TP-0184
2 clinical trials
1 abstract
3 indications
Indication
CancerIndication
Anemia in Myelodysplastic SyndromesIndication
Breast CancerClinical trial
A Phase I, First-in-human, Open-label, Dose-escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Oral TP-0184 Administered Once Weekly for 4 Weeks to Patients With Advanced Solid TumorsStatus: Completed, Estimated PCD: 2021-03-08
Clinical trial
A Phase 1/2, Open-Label Clinical Study To Evaluate Safety And Efficacy Of TP-0184 To Treat Anemia When Administered To Adult Patients With IPSS-R Low Or Intermediate Risk Myelodysplastic SyndromesStatus: Terminated, Estimated PCD: 2021-04-27